Russell Investments Group, Ltd. Rocket Pharmaceuticals, Inc. Transaction History

Russell Investments Group, Ltd.

$66.8 Billion
Q3 2024

A detailed history of Russell Investments Group, Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Russell Investments Group, Ltd. holds 812,310 shares of RCKT stock, worth $9.55 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

812,310

Previous 677,744 19.85%

Holding current value

$9.55 Million

Previous $14.6 Million 2.82%

% of portfolio

0.02%

Previous 0.02%

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$17.6 - $25.88 $2.37 Million - $3.48 Million	134,566 Added 19.85%	812,310 $15 Million
Q2 2024 Aug 08, 2024	BUY	$20.66 - $26.72 $40,803 - $52,772	1,975 Added 0.29%	677,744 $14.6 Million
Q1 2024 May 08, 2024	BUY	$26.16 - $30.74 $701,689 - $824,539	26,823 Added 4.13%	675,769 $18.2 Million
Q4 2023 Feb 05, 2024	SELL	$16.78 - $31.94 $1.33 Million - $2.54 Million	-79,463 Reduced 10.91%	648,946 $19.4 Million
Q3 2023 Nov 13, 2023	BUY	$15.07 - $24.05 $2.17 Million - $3.46 Million	143,695 Added 24.58%	728,409 $14.9 Million
Q2 2023 Aug 10, 2023	BUY	$16.59 - $23.6 $1.31 Million - $1.87 Million	79,192 Added 15.67%	584,714 $11.6 Million
Q1 2023 May 09, 2023	BUY	$15.79 - $22.6 $1.98 Million - $2.84 Million	125,476 Added 33.02%	505,522 $8.66 Million
Q4 2022 Feb 08, 2023	BUY	$15.5 - $22.76 $3.1 Million - $4.55 Million	199,945 Added 111.02%	380,046 $7.44 Million
Q3 2022 Nov 04, 2022	BUY	$12.37 - $18.41 $83,930 - $124,911	6,785 Added 3.91%	180,101 $2.87 Million
Q2 2022 Jul 29, 2022	BUY	$7.96 - $16.64 $1.38 Million - $2.88 Million	173,316 New	173,316 $2.38 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $890M
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Russell Investments Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Russell Investments Group, Ltd. with notifications on news.

Account

Russell Investments Group, Ltd. Rocket Pharmaceuticals, Inc. Transaction History